Work

Design of the FIBRONEER-ON open-label extension trial of nerandomilast (BI 1015550)

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa672

Authors: Wim A. Wuyts, Luca Richeldi, Shervin Assassi, Arata Azuma, Vincent Cottin, Anna-Maria Hoffmann-Vold, Michael Kreuter, Justin M. Oldham, Fernando J. Martinez, Claudia Valenzuela, Marlies S. Wijsenbeek, Madhu Kanakapura, Alexandra James, Cyril Drzewuski, Carl Coeck, Toby M. Maher

Institutions: Universitair Ziekenhuis Leuven, Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Nippon Medical School, Lyon 1 Université, Hospices Civils de Lyon, Hôpital Louis Pradel, Oslo University Hospital, Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz, University of Michigan, Michigan Medicine, Cornell University, Hospital Universitario de La Princesa, Universidad Autónoma de Madrid, Erasmus MC, Boehringer Ingelheim (Germany), Boehringer Ingelheim (Belgium), University of Southern California

Language: English

Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404103373

Cites:

Cited by: 1

Related to: 10